Wy-14,643 and fenofibrate inhibit mitochondrial respiration in isolated rat cardiac mitochondria

Mitochondrion. 2006 Dec;6(6):315-22. doi: 10.1016/j.mito.2006.09.001. Epub 2006 Sep 7.

Abstract

We investigated the direct effects of two selective PPARalpha ligands, fenofibrate and Wy-14,643, on mitochondrial respiratory function using isolated rat cardiac mitochondria. Isolated left ventricular mitochondria were incubated with increasing concentrations of fenofibrate or Wy-14,643 (10, 100, and 500 microM) and mitochondrial respiration determined using: malate/glutamate (complex I), succinate (complex II) and palmitoyl-l-carnitine as oxidative substrates. Our data show that acute exposure to Wy-14,643 and fenofibrate differentially perturb cardiac mitochondrial respiration i.e., fenofibrate more potently inhibited mitochondrial respiration and bioenergetic capacity compared to Wy-14,643. Moreover, we found that both agents increased uncoupling of mitochondrial oxidative phosphorylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Respiration / drug effects
  • Dose-Response Relationship, Drug
  • Fenofibrate / pharmacology*
  • Male
  • Mitochondria, Heart / drug effects*
  • Mitochondria, Heart / metabolism*
  • Myocardium / cytology*
  • Pyrimidines / pharmacology*
  • Rats
  • Rats, Wistar

Substances

  • Pyrimidines
  • pirinixic acid
  • Fenofibrate